COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,676 Articles (22,913 medRxiv, 8,763 bioRxiv)

Most recent first Previous |  Page 622: Articles 6211-6220  | Next

Optimization of the Illumina COVIDSeq™ protocol for decentralized, cost-effective genomic surveillance
Carpenter, R. E., Tamrakar, V. K., Almas, S., Rowan, C., Sharma, R.
10.1101/2022.11.07.515545 — Posted: 2022-11-08
Enhanced stability of the SARS CoV-2 spike glycoprotein trimer following modification of an alanine cavity in the protein core.
Poumbourios, P., Langer, C., Boo, I., Zakir, T., Center, R. J., Akerman, A., Milogiannakis, V., Aggarwal, A., Turville, S. G., Drummer, H. E.
10.1101/2022.11.08.515567 — Posted: 2022-11-08
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection.
Milighetti, M., Peng, Y., Tan, C. C. S., Mark, M., Nageswaran, G., Byrne, S., Ronel, T., Peacock, T., Mayer, A., Chandran, A., Rosenheim, J., Wheelan, M., Yao, X., Liu, G., Felce, S. L., Dong, T., Mentzer, A. J., Knight, J. C., Balloux, F., Greenstein, E., Reich-Zeliger, S., Pade, C., Gibbons, J. M., Semper, A., Brooks, T., Otter, A., Altmann, D. M., Boyton, R. J., Maini, M. K., McKnight, A., Manisty, C., Treibel, T. A., Moon, J. C., COVIDsortium Investigators, , Noursadeghi, M., Chain, B.
10.1101/2022.11.08.515436 — Posted: 2022-11-08
Durability and determinants of anti-SARS-CoV-2 spike antibodies following the second and third doses of mRNA COVID-19 vaccine
Yamamoto, S., Oshiro, Y., Inamura, N., Nemoto, T., Horii, K., Okudera, K., Konishi, M., Ozeki, M., Mizoue, T., Sugiyama, H., Aoyanagi, N., Sugiura, W., Ohmagari, N.
10.1101/2022.11.07.22282054 — Posted: 2022-11-08
Too much is too much: influence of former stress levels on food cravings and weight gain during the COVID-19 period
Granger, R. L., Kubis, H. P.
10.1101/2022.11.06.22282004 — Posted: 2022-11-08
TRANSCUTANEOUS VAGUS NERVE STIMULATION IN THE TREATMENT OF LONG COVID-CHRONIC FATIGUE SYNDROME
Natelson, B., Blate, M., Soto, T.
10.1101/2022.11.08.22281807 — Posted: 2022-11-08
Changes in Alcohol Consumption during the COVID-19 Pandemic: Evidence from Wisconsin
Pomazal, R., McCulley, L., Schultz, A., Stafford, N., Schowalter, M., Malecki, K.
10.1101/2022.11.07.22282029 — Posted: 2022-11-07
Systematic review of the prevalence of Long Covid
Woodrow, M. C., Carey, C., Ziauddeen, N., Thomas, R., Akrami, A., Lutje, V., Greenwood, D. C., Alwan, N. A.
10.1101/2022.11.06.22281979 — Posted: 2022-11-07
Systematic review of the clinical effectiveness of Tixagevimab/Cilgavimab for prophylaxis of COVID-19 in immunocompromised patients
Suribhatla, R., Starkey, T., Ionescu, M. C., Pagliuca, A., Richter, A., Lee, L. Y.
10.1101/2022.11.07.22281786 — Posted: 2022-11-07
A comprehensive knowledgebase of known and predicted human genetic variants associated with COVID-19 susceptibility and severity
Kars, M. E., Stein, D., Sevim Bayrak, C., Stenson, P. D., Cooper, D. N., Itan, Y.
10.1101/2022.11.03.22281867 — Posted: 2022-11-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).